ABSTRACT
Conclusion Serial assessment of maternal hemodynamics in high-risk women identifies distinctive trends associated with pregnancies destined to deliver babies with birth weights < 10 th and < 5 th percentiles. These pregnancies have a suppressed and static maternal cardiac output and stroke volume, and have consistently raised peripheral vascular resistance. This suggests that, in women with chronic hypertension or a history of hypertensive disorder in a previous pregnancy, FGR is associated with a primary and persistent failure of maternal cardiovascular

INTRODUCTION
Fetal growth restriction (FGR) is a major cause of perinatal mortality and morbidity, with a direct relationship between lower birth weight and worsening neonatal outcomes. Traditionally, the 10 th percentile has been used as a cut-off to indicate FGR, with a progressive increase in rates of stillbirth and neonatal death with reducing birth weights from the 10 th to the 3 rd percentile 1 . Infants born below the 10 th , 5 th and 3 rd percentiles have a twofold 1 , four-to sevenfold 1,2 and four-to eightfold 1, 3 increase in risk of neonatal death, respectively.
Diagnosis of FGR, and the scope that it allows for increased surveillance and timing of delivery, reduces perinatal mortality by around 50% 2, 4 . In addition, early detection of high-risk pregnancy allows for intervention, such as aspirin, which substantially lowers the risk of O R I G I N A L P A P E R used to screen for FGR 6 . By combining maternal demographic and hemodynamic data in the first trimester, we showed that a detection rate of 100% can be achieved for babies with a birth weight under the 5 th percentile, at a false-positive rate of 35%. This screening modality is particularly useful in a high-risk population in which other established methods of screening, such as uterine artery Doppler, maternal history or blood pressure, are less effective [7] [8] [9] . Findings from previous studies in the first 10 , second 11, 12 and third 11, 12 trimesters are in keeping with those detailed above, i.e. that pregnancies complicated by FGR are characterized by high maternal vascular resistance and low cardiac output. However, there is little information regarding the sequence of these changes due to a paucity of longitudinal studies of the maternal hemodynamics in these pregnancies.
In this study, we sought to determine whether this distinctive maternal hemodynamic profile associated with FGR persists throughout pregnancy by serially monitoring maternal hemodynamics from the time of booking until the immediate peripartum period. We hoped that this would not only help to determine the underlying pathophysiology of FGR, but also allow for the elaboration of a more effective screening method and help to inform possible interventions aimed at improving maternal cardiovascular adaptation to pregnancy.
PATIENTS AND METHODS
Study population
This was a prospective observational cohort study at a dedicated clinic for pregnancies complicated by hypertension at King's College Hospital, London, UK. Approval was granted by the local ethics committee (NRES Committee London -Fulham, REC reference: 12/LO/1593). Eighty-four women were enrolled consecutively between January and December 2013. Fifty-four of these women were referred due to a history of hypertension in a previous pregnancy and 30 owing to a history of chronic hypertension (11 of these also had a previous history of hypertension in pregnancy).
Maternal demographics and hemodynamics were assessed at presentation to the clinic. Thereafter, women were reviewed regularly until delivery and hemodynamics were assessed serially. We aimed to assess hemodynamics at least once in each trimester. Women who did not develop hypertension requiring treatment and who did not have any signs of FGR were seen shortly after booking and then again at 24, 28 and 36 weeks' gestation. Women who developed signs of FGR or who had hypertension requiring treatment, or both, were seen more regularly, in keeping with their clinical condition.
All women underwent ultrasound scans every 4 weeks after 28 weeks' gestation and more regularly if clinically indicated. The decision to deliver for FGR differed for early and late FGR, and was based on the protocol of Figueras and Gratacós 13 .
The demographic details recorded at presentation included the following variables: age, height, weight, body surface area (BSA), ethnicity, cigarette smoker (yes/no), medical history (including chronic hypertension, asthma, renal disease, diabetes mellitus), medication (including antihypertensives, antiasthmatics, antidiabetics) and parity (nulliparous, parous with no previous hypertension in pregnancy, parous with previous hypertension in pregnancy). Maternal ethnicity was self-reported and recorded as Black (including Black-African and Afro-Caribbean), Caucasian or other.
Outcome measures
We compared maternal demographic and serial hemodynamic parameters between women who delivered infants with birth weights < 10 th vs ≥ 10 th percentile and < 5 th vs ≥ 5 th percentile (the latter is presented as supplementary material).
Maternal outcomes were obtained from local records and databases. Pre-eclampsia and pregnancy-induced hypertension were defined according to the International Society for the Study of Hypertension in Pregnancy 14 . Fetal birth-weight percentiles, calculated as described by Royston and Wright 15 , were based on locally derived reference ranges 16 .
In addition, we sought to establish the prevalence of FGR, as defined recently by Figueras and Gratacós (FGR-US) 13 , within the < 5 th and < 10 th percentile groups. We have referred to this FGR as FGR-US as this definition incorporates ultrasound markers of pathological fetal growth, such as abnormal fetal Doppler (defined as umbilical artery pulsatility index > 95 th percentile or cerebroplacental ratio < 5 th percentile) or oligohydramnios (deepest pool < 5 th percentile) as well as a more stringent birth-weight cut-off of < 3 rd percentile.
Hemodynamic measurements
A non-invasive cardiac output monitor using bioreactance technology was used to record maternal hemodynamic data (NICOM, Cheetah Medical Ltd, Maidenhead, Berkshire, UK). Bioreactance makes use of the relative phase shifts that occur when an alternating electrical current traverses the thoracic cavity in order to calculate stroke volume. Paired measurements from the NICOM device and echocardiography were taken in a sample of 20 patients, separate from the study cohort, for calculating stroke volume and cardiac output as described in our previous work 6, 17 . Blood pressure was monitored with an automated device validated for use in pregnancy and pre-eclamsia 18 , and measurements were taken according to the British Hypertension Society guidance 19 . The first hemodynamic measurement was recorded at an average of 14.3 weeks' gestation, the second at an average of 20.7 weeks' gestation and the third at an average of 30.4 weeks' gestation. The majority of women (n = 45) had four or more hemodynamic measurements taken and 25 had five or more hemodynamic measurements.
Statistical analysis
The Kolmogorov-Smirnov test was used to calculate the normality of the continuous numerical data. Normally distributed data and non-normally distributed data were compared using unpaired t-test and Mann-Whitney U-test, respectively. Categorical data were compared between the two groups using the chi-square or Fisher's exact test, where appropriate.
Sample size
We used the R package simr to calculate the power for linear mixed models. The power calculations were based on Monte Carlo simulations given the longitudinal structure of the data. We constructed power curves to assess trade-offs between power and sample size.
In this study we aimed to examine the longitudinal changes of hemodynamic indices throughout pregnancy and we based our power calculations on the expected increase in cardiac output during gestation. The average cardiac output was 6.83 L/min before 12 weeks' gestation and a 40% increase was anticipated until 30 weeks' gestation. Thus, we set the effect size for cardiac output slope (coefficient of gestational age) at + 0.15. The relationship between sample size (number of women participating in the study) and power for the predictor 'gestational age' is depicted in Figure S1 . Ten women with repeated measurements was the threshold to achieve 80% power for an α-level set at 0.05. The number of Monte Carlo simulations was 1000 for all analyses.
Longitudinal data analysis
A multilevel mixed-effects linear model was fitted due to the longitudinal structure of the data, as described by Royston and Altman 20 . Specifically, we fitted a randomintercept, random-slopes model. Multilevel modeling assumes that fixed intercepts and coefficients are the same across different levels, whereas random intercepts and slopes are allowed to vary across different levels. An important advantage of the mixed-effects model is that it accounts for the positive correlation between the measurements that are observed within the same patient to calculate the so-called within-subject variation (repeated measurements). Additionally, the biological variability in the longitudinal outcome (between-subject variation) is modeled.
Maternal hemodynamic indices, namely mean arterial pressure, peripheral vascular resistance, cardiac output, heart rate and stroke volume, were the dependent variables. Gestational age, maternal age, maternal height, maternal weight, BSA, parity (nulliparous, parous with previous pregnancy with hypertension, parous with no previous pregnancy with hypertension), ethnicity and smoking status were inserted as independent fixed parameters in the model.
The presence of FGR, as defined by Figueras and Gratacós 13 , was examined in the form of a binary variable named FGR-US. We used a second-degree term for the gestational age (GA 2 ) in the fixed part of the model to capture a possible non-linear trend. The random-part component was a random-intercept, random-slope model. The group of repeated measurements for each subject constituted Level 1 and each measurement contributed to the quantification of residual random variance.
We simultaneously allowed random slopes for gestational age. A likelihood ratio test was applied to assess the significance of the random part. For variables for which the random part was non-significant, the model was reduced to a random-intercept model and, if the random part was still non-significant, a conventional linear regression analysis was carried out and the residual SD was computed. In analyses in which gestational age was non-significant in the fixed part of the model, we removed the random slopes for gestational age and a random-intercept model was constructed. We used a restricted maximum-likelihood algorithm to parameterize the model. Akaike information criterion and Bayesian information criterion were used to compare intermediate models.
The 
RESULTS
In our study cohort of 84 women, 68 (81%) delivered babies ≥ 10 th percentile and 16 (19%) delivered babies < 10 th percentile with 73 (87%) delivering babies ≥ 5 th percentile and 11 (13%) delivering babies < 5 th percentile (the demographic and longitudinal data analysis for the latter group is presented as supplementary material in Tables S1-S5) .
Maternal demographic and hemodynamic data at presentation and pregnancy outcome
Maternal demographics at presentation for the two groups are shown in Table 1 . The group of women who delivered babies < 10 th percentile were significantly more likely to be shorter, lighter and have a smaller BSA than the group that delivered babies ≥ 10 th percentile. There was no significant difference between the two groups in terms of maternal age, smoking status, parity, history of previous hypertensive disorder in pregnancy, ethnicity or past medical history.
Maternal hemodynamic data at presentation and pregnancy outcomes for the two groups are also presented in Table 1 . At presentation, there were no significant differences between the two groups in terms of gestational age, diastolic blood pressure or mean arterial blood Data are given as mean ± SD, median (interquartile range) or n (%). FGR-US, fetal growth restriction with ultrasound markers of pathological growth.
pressure. Women who went on to deliver babies with a birth weight < 10 th percentile were significantly more likely to have, at presentation, lower cardiac output, systolic blood pressure and stroke volume, and higher peripheral vascular resistance than women who delivered babies with a birth weight ≥ 10 th percentile. There was a trend towards a higher heart rate among those women who delivered babies < 10 th percentile, although this difference did not reach statistical significance.
Both groups of women (birth weight ≥ 10 th and < 10 th percentile) delivered at similar gestational ages and had similar rates of pre-eclampsia and pregnancy-induced hypertension. More than half of the babies born with a birth weight < 10 th percentile had ultrasound evidence of FGR-US compared with none of the babies with a birth weight ≥ 10 th percentile. Compared with those ≥ 10 th percentile, babies < 10 th percentile were four times more likely to be admitted to the neonatal unit and six times more likely to have postnatal hypoglycemia.
Longitudinal data analysis
The results of the longitudinal analysis are presented for the two cohorts (< 10 th percentile and ≥ 10 th percentile) in Tables 2 and 3 and Figure 1 . Tables S2-S5 provide the longitudinal data analysis for the two cohorts with birth weight above and below the 5 th percentile. The independent variables in the fixed models are presented, but estimates, standard errors and P-values are provided only for the significant parameters in order to simplify the presentation of the data. 
Variables are presented as estimate and standard error (SE). *Null hypothesis: variance due to random effects = 0. AIC, Akaike information criterion; BIC, Bayesian information criterion; BSA, body surface area; FGR, fetal growth restriction; GA, gestational age; GA 2 , second-degree term for gestational age; LR, likelihood ratio; PE, pre-eclampsia.
In pregnancies with birth weight ≥ 10 th percentile, longitudinal maternal hemodynamic variables generally showed a pattern consistent with the known physiological changes in pregnancy. Cardiac output (Table 2, Figure 1a) showed changes with gestational age in a quadratic mode, reaching a peak in mid-pregnancy and declining thereafter. Mean arterial pressure and peripheral vascular resistance (Table 2, Figure 1b) showed changes with gestational age in a quadratic mode, reaching a nadir in mid-pregnancy and increasing thereafter. Stroke volume declined linearly with gestation, after starting at a higher level at presentation (Table 2, Figure 1c) , whereas heart rate increased in a quadratic fashion with a decline after 30 weeks' gestation.
Pregnancies with birth weight < 10 th percentile had longitudinal maternal hemodynamic variables that showed a static pattern with little longitudinal change with gestation. Cardiac output and stroke volume (Table 3, Figure 1 ) were lower at presentation and remained suppressed and unchanged throughout gestation. Peripheral vascular resistance (Table 3, Figure 1b ) was higher at presentation and remained elevated and static throughout gestation. Heart rate ( Table 3) remained static throughout gestation, whereas mean arterial pressure (Table 3) demonstrated a quadratic change with a reduction until mid-pregnancy and an increase thereafter.
BSA was an independent predictor of longitudinal changes during pregnancy for cardiac output in both cohorts and for stroke volume and peripheral vascular resistance in women with fetal birth weight ≥ 10 th percentile.
Similar differential hemodynamic patterns were present in pregnancies above and below the 5 th percentile (Tables  S1-S5 ).
DISCUSSION
This study shows that women with high-risk pregnancies who deliver babies with birth weights below the 10 th or 5 th percentile have an impaired cardiovascular 
Variables are presented as estimate and standard error (SE). *Null hypothesis: variance due to random effects = 0. AIC, Akaike information criterion; BIC, Bayesian information criterion; BSA, body surface area; FGR, fetal growth restriction; GA, gestational age; GA 2 , second-degree term for the gestational age; LR, likelihood ratio; PE, pre-eclampsia. adaptation to pregnancy, which endures longitudinally throughout their gestations. They show a suppressed and static cardiac output and stroke volume, and have consistently raised vascular resistance, which fails to demonstrate the dynamic change that is seen in those with appropriate-for-gestational-age babies. These differences were present even after controlling for maternal demographic characteristics.
In women with well-grown babies, the longitudinal changes in maternal hemodynamics were consistent with what is known about cardiovascular adaptation to pregnancy. In normal pregnancy, an early reduction in peripheral vascular resistance is followed by activation of the renin-angiotensin system and downregulation of the threshold for antidiuretic hormone secretion 21 , giving a 40% increase in plasma volume and a concomitant rise in cardiac output, peaking around 30 weeks' gestation 22 . In our data, this decline in vascular resistance and increase in cardiac output occurred until mid-pregnancy, at which point cardiac output fell and resistance escalated. In this group, both heart rate and stroke volume declined towards the end of pregnancy, a slight deviation from observed changes in normal pregnancy, possibly due to either the characteristics of this high-risk cohort or an effect of their antihypertensive treatment. We note that a high proportion of women in this group (53/68) were on antihypertensives, most commonly a beta-blocker.
Conversely, in women who delivered babies with birth weights below the 10 th or 5 th percentile there was a stark and sustained failure of cardiovascular adaptation. Their static cardiac output and persistently raised vascular resistance indicate a primary failure of vasodilatation and plasma volume expansion found in normal pregnancy. In addition, the trend for a higher heart rate at presentation among this group may be an adaptive response allowing for a partial compensation of poorer placental perfusion owing to their relatively restricted stroke volume. Furthermore, this cohort did not show the same dynamic longitudinal change in heart rate demonstrated by those with babies with a birth weight ≥ 10 th percentile. Instead, their heart rate remained static, in close correlation with their fixed stroke volume.
This study provides longitudinal corroboration of previous cross-sectional work in the first 10 and third 11, 12 trimesters, which has shown a linear relationship between lower cardiac output and reduced fetal growth. Khaw et al. 10 examined 534 nulliparous women in the first trimester and showed that those women who delivered babies < 10 th percentile had a suppressed cardiac output and an increased peripheral vascular resistance. Similarly, Bamfo et al. 11 showed reduced cardiac output, stroke volume and left atrial diameter (a marker of preload), and an increased peripheral vascular resistance in 26 women with growth-restricted fetuses at 20-36 weeks' gestation, compared with 26 women with fetuses with birth weights below the 10 th centile but no ultrasound feature of growth restriction. More recently, Melchiorre et al. 12 examined 54 women with FGR in the third trimester (25 had pre-eclampsia) and found that they had lower maternal cardiac indices and higher vascular resistance than did controls. In addition to these studies, Vasapollo et al. 23 also showed that vascular resistance at 24 weeks' gestation is strongly positively correlated with a composite outcome of pregnancy and neonatal complications, including FGR.
Serial hemodynamic monitoring has also been performed by Rang et al. 24 . Their study, which recruited a divergent group of 42 women (21 nulliparous and 21 parous with a previous history of pre-eclampsia), showed that the four women who developed FGR had consistently elevated vascular resistance and a suppressed cardiac output, in keeping with our work. This study also showed that women with growth-restricted babies, both with and without pre-eclampsia, had a reduced cardiac output and elevated vascular resistance prior to pregnancy, suggesting not only a failure of adaptation but also an antecedent and distinct hemodynamic profile in those destined to deliver smaller babies. We note that it is a potential limitation of our study that we were not able to record prepregnancy hemodynamics because of the referral pathway to our hypertension clinic.
These findings of failed cardiovascular adaptation with static low cardiac output and high peripheral vascular resistance throughout pregnancy have implications from a screening and a therapeutic perspective. We have shown previously that, in women at high risk of FGR, a prediction model to anticipate growth under the 5 th percentile, incorporating maternal demographics and hemodynamics assessed late in the first trimester, provides a tool for triaging these pregnancies, with 100% sensitivity for a 35% false-positive rate 6 . As the current study shows, the maternal cardiovascular variables diverge between the two groups with advancing gestation, with maximal divergence at about 25 weeks' gestation. Screening at this point may therefore have an even more robust predictive potential.
That a causal connection, and not just a correlation, exists between fetal growth and maternal cardiac performance, is strongly suggested by Easterling et al. 25 . They have shown that, by closely monitoring cardiac output during antihypertensive therapy with beta blockade and by reducing dosage to avoid suppressing cardiac output, fetal growth can be better maintained.
Given the persistent high-resistance, low-output hemodynamic state associated with growth-restricted pregnancies, therapeutic options for hypertension in this group may further jeopardize already impaired placental perfusion. We note the findings of a subgroup analysis of the CHIPS trial 26 , which showed that labetalol, compared with methyldopa, was associated with a higher incidence of fetal birth weights below the 10 th percentile. It may be that the negative chronotropic effect of labetalol 27 impedes what is in fact an adaptive relative tachycardia functioning to maintain placental blood flow despite a suppressed cardiac output. We also note that our finding of higher heart rate at presentation in the cohort who had FGR is consistent with that of a study by Rang et al. 28 , showing that women who developed pre-eclampsia (a group with smaller mean birth weights than the normotensive group in this study) had an increased level of resting sympathetic activity and a trend towards a higher heart rate from early in pregnancy compared with those women without pre-eclampsia. The alternative therapeutic option for hypertension, namely vasodilators, may reduce vascular resistance and blood pressure but, given the lack of preload expansion, they may also further compromise placental perfusion.
In conclusion, we have shown that maternal hemodynamics in high-risk growth-restricted pregnancies are characterized by a persistently suppressed and static cardiac output with a similarly static but elevated vascular resistance. Effective screening for growth restriction by maternal hemodynamics appears to be optimal at midpregnancy, and treatment for hypertension in pregnancy against the backdrop of this pathological hemodynamic profile may risk further impeding placental perfusion.
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